Investigating ABCB1-Mediated Drug-Drug Interactions: Considerations for In vitro and In vivo Assay Design
Zsolt Sáfár, Balázs Vaskó, Tasha K Ritchie
1Solvo Biotechnology, Gyár u. 2, Budaörs, 2040 Hungary. krajcsi@solvo.com.
Current Drug Metabolism
|January 6, 2016
Summary
Understanding ABCB1 transporter function is key for drug development. This review covers ABCB1 drug transport, interactions, and models, highlighting complex kinetics and clinical relevance for drug-drug interactions.
Area of Science:
- Pharmacology
- Biochemistry
- Drug Metabolism
Background:
- ABCB1 (P-glycoprotein) is a crucial efflux transporter impacting drug pharmacokinetics and mediating drug-drug interactions (tDDIs).
- It is the most frequently studied transporter for tDDIs in both in vitro and clinical settings.
Purpose of the Study:
- To review regulatory aspects, models, and methods for assessing ABCB1-mediated drug transport and inhibition.
- To discuss the complex kinetics, protein structure, and mechanistic aspects of ABCB1 transport.
Main Methods:
- Review of existing literature on ABCB1 function, drug interactions, and modeling approaches.
- Analysis of factors influencing in vitro and in vivo transporter activity, including expression systems and lipid composition.
Main Results:
- ABCB1 exhibits complex kinetics with multiple binding sites, potentiation, and probe-dependent IC50 values.
- Drug permeability and expression system characteristics significantly affect observed transporter activity.
- Clinical tDDIs involving ABCB1 are often complex due to the involvement of multiple transporters and metabolic enzymes, potentially masking ABCB1's specific role.
Conclusions:
- Refined simulations will enhance the use of in vitro data for predicting drug behavior.
- Humanized preclinical models are expected to significantly improve the understanding and prediction of transporter-mediated effects.
More Related Videos
08:46Implementation of In Vitro Drug Resistance Assays: Maximizing the Potential for Uncovering Clinically Relevant Resistance Mechanisms
Published on: December 9, 2015
11.3K
07:40A Data Integration Workflow to Identify Drug Combinations Targeting Synthetic Lethal Interactions
Published on: May 27, 2021
4.7K
Related Concept Videos
01:30Drug toxicity: Drug–Drug Interaction
325
Drug–drug interactions can precipitate toxicity through multiple mechanisms. Absorption interactions alter how drugs enter the body, exemplified when ranitidine increases the absorption of basic drugs, while cholestyramine decreases the levels of propranolol. Protein binding interactions occur when drugs share the same binding sites on plasma proteins. Drugs like aspirin and warfarin, when bound in excess, can lead to increased free drug concentrations, enhancing the potential for...
325
01:20Drug Product Performance: In Vitro–In Vivo Correlation
374
In pharmaceutical development, it's crucial to establish a predictive in vitro–in vivo correlation (IVIVC) for two or more formulations to gain a comprehensive understanding of release properties. IVIVC reduces the need for costly in vivo studies and facilitates the establishment of meaningful dissolution specifications with significant cost savings and decreased regulatory burden. Furthermore, a meaningful IVIVC should predict Cmax and AUC within 20%, aligning with FDA guidance while...
374
01:25Pharmacokinetics: Drug–Drug Interactions
656
Drug interactions occur when the pharmacological effect of one drug is altered by another substance, either enhancing or diminishing its activity. The drug whose activity is altered is known as the object drug, and the substance causing the alteration is called the agent drug or the precipitant. The net effects of these interactions are mostly undesirable, leading to decreased effectiveness or increased adverse effects. In rare cases, interactions can be beneficial, such as the enhanced...
656
01:16Methods for Studying Drug Absorption: In vitro
751
In vitro experiments are crucial for understanding the transport and absorption of drugs through biological materials. These studies employ varied methods such as the diffusion cell method, the everted sac technique, and the everted ring technique.
The diffusion cell method uses a two-compartment cell, including a donor compartment with the drug solution, which simulates the environment where the drug is applied, and a receptor compartment with a buffer solution, which simulates the environment...
The diffusion cell method uses a two-compartment cell, including a donor compartment with the drug solution, which simulates the environment where the drug is applied, and a receptor compartment with a buffer solution, which simulates the environment...
751
01:28Structure-Activity Relationships and Drug Design
2.0K
Drug design is a dynamic field that involves discovering and developing new medications based on specific biological targets. This process heavily relies on structure-activity relationships (SAR) and quantitative structure-activity relationships (QSAR) to guide the design and optimization of efficient drugs.
SAR studies the intricate relationship between a drug's chemical structure and biological activity. It focuses on understanding how modifications to a drug's structure can influence...
SAR studies the intricate relationship between a drug's chemical structure and biological activity. It focuses on understanding how modifications to a drug's structure can influence...
2.0K
01:16Drug toxicity: Idiosyncratic Reactions
165
Idiosyncratic drug reactions represent abnormal chemical responses that vary significantly among individuals, ranging from extreme sensitivity to low doses to insensitivity to high doses. These reactions often occur due to the drug's covalent binding with serum proteins, forming a foreign hapten that triggers an immunotoxicological response. The variability in drug reactions has a strong pharmacogenetic foundation, with genetic differences crucial in how individuals metabolize drugs. For...
165